18.97.14.84
dgid:
enl:
npi:0
-Advertisement-

Autoimmune PAP

Inhaled molgramostim shows long-term benefits for aPAP patients in real-world case series

Inhaled molgramostim, a recombinant GM-CSF, shows promising long-term therapeutic benefits for patients with autoimmune pulmonary alveolar proteinosis (aPAP), according to a real-world case series. Currently, the standard treatment for aPAP is whole-lung lavage, however, whole-lung lavage does not address the underlying cause of the disease. As a result, there is...

Read More
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-